Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study

The standard treatment for platinum-sensitive relapsed ovarian cancer (PSROC) is platinum-based chemotherapy followed by olaparib monotherapy. A retrospective study was conducted to identify factors affecting the survival of patients with PSROC undergoing olaparib monotherapy in real-world clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashiro, Ryota, Kawazoe, Hitoshi, Mamishin, Kanako, Seto, Keisuke, Udagawa, Ryoko, Saito, Yoshimasa, Hashimoto, Hironobu, Shimoi, Tatsunori, Yonemori, Kan, Yonemura, Masahito, Terakado, Hiroyuki, Nishimura, Takahiro, Kawasaki, Toshikatsu, Furukawa, Tetsuya, Nakamura, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366208/
https://www.ncbi.nlm.nih.gov/pubmed/37488223
http://dx.doi.org/10.1038/s41598-023-39224-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366208/
https://www.ncbi.nlm.nih.gov/pubmed/37488223
http://dx.doi.org/10.1038/s41598-023-39224-0

Ejemplares similares